To Evaluate the Pharmacokinetic of Diacerein and Rhein After Maximum Use in Patients With Epidermolysis Bullosa (EB)

NCT03472287 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Epidermolysis Bullosa (EB)
Epidermolysis Bullosa Simplex
Dystrophic Epidermolysis Bullosa
Junctional Epidermolysis Bullosa

Interventions

DRUG: Diacerein 1% Ointment

Sponsor

Castle Creek Pharmaceuticals, LLC